Assembly Biosciences Inc. held its Annual Meeting of Stockholders on June 5, 2025. Stockholders approved amendments to the 2018 Stock Incentive Plan, increasing shares reserved for issuance from 1,103,333 to 1,478,333. Another amendment to the Employee Stock Purchase Plan was approved, increasing shares from 164,500 to 225,000. Additionally, William R. Ringo, Jr., Anthony E. Altig, Tomas Cihlar, Ph.D., Gina Consylman, Robert D. Cook II, Sir Michael Houghton, Ph.D., Lisa R. Johnson-Pratt, M.D., Susan Mahony, Ph.D., John G. McHutchison, A.O., M.D., and Jason A. Okazaki were elected to the Board of Directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.